ABOUT EXPERTISE VENTURES NSIC CAREERS CONTACT 日本支社 Biomedical sciences SRI Biosciences delivers next-generation drugs, diagnostics and devices to solve unmet medical needs. We work with partners to develop transformative approaches and platforms for the toughest therapeutic problems. CONTACT US Our innovation strategies are built on more than 50 years of drug development and discovery experience. We’ve refined our ability to repeat biomedical discovery and catalyze innovation into new products. Ian M. Colrain President, Biosciences Division Some of our innovators Parijat Bhatnagar Program Director, Cell-based Medicine; Center for Chemical Biology Kathlynn Brown Senior Director, Macromolecular Sciences Massimiliano de Zambotti Research Scientist, Human Sleep Research Program, Center for Health Sciences Nathan Collins Chief Strategy Officer Peter Madrid Senior Director and Head of Applied Biosciences Gita Shankar Director, Formulations R&D, Pharmaceutical Sciences Michael Greenstein Sensing and Diagnostics Lab Director, SRI Biosciences Our latest PRESS RELEASE JULY 7, 2021 SRI International enters drug discovery and research collaboration with Sanofi Researchers will leverage SynFini, SRI’s artificial intelligence and automation platform, to accelerate development of small-molecule drug targets ANNOUNCEMENTS JULY 12, 2021 SRI International’s Parijat Bhatnagar receives DARPA award to continue groundbreaking research… The prestigious award provides additional funds to continue developing cells that can be stimulated via extracorporeal devices to treat viral infections RESEARCH AND DEVELOPMENT DECEMBER 8, 2020 The mental health impact of COVID-19 restrictions How did pandemic isolation and pandemic-related changes affect individuals around the globe? View more Areas of expertise Collaborative research Neuroimaging and electrophysiological research Sleep device design and validation Adolescent development Translational approaches using in vivo MRI Translational neuroscience Drug discovery Technology platforms for new approaches to drug discovery Small molecule and biologic therapies AI-driven drug design Target validation and assay development and screening Lead identification, optimization and synthesis Diagnostics and devices Fiber-optic Array Scanning Technology (FAST) rare cell detection High-speed hyperspectral imaging Wearable sleep technology Diagnostic biomarker discovery SynFini: automated chemistry design and synthesis Chemical and biological sensing solutions Product development services Pharmacology, efficacy and predictive ADMET Safety, drug metabolism and pharmacokinetics Formulation design Clinical drug product manufacturing Clinical trials Platforms SRI Biosciences’ highly specialized platforms marry the advantages of our cutting-edge research with our flexible biotech business model. Partner with us to leverage our rigorous early discovery and development to customize your specific applications. FOX Three Molecular Guidance System™ Cell-selective, intracellular delivery of macromolecular therapeutics: Deliver essentially any cargo to selected cell types, and internalize into those cells to targeted subcellular locations. Learn more SynFini™ Suite of automated tools leverages AI to recreate and scale literature-reported synthesis procedures. Solutions focus on key areas of route design, reaction screening and optimization (RSO), and multi-step synthesis development. Learn more Techneins™ Non-natural polymers as synthetic affinity reagents and novel therapeutics Learn more Synthetic Lethals AI-guided precision cancer therapy platform provides a new approach to finding targeted therapies for previously “undruggable mutations.” Learn more Fields of research We work with commercial, government and academic clients and partners to help save and improve lives worldwide. Our leading-edge R&D is concentrated in the following areas to solve important problems in prevention, diagnosis and treatment. Human sleep Point of care diagnostics Aging and neurodegenerative diseases Neuroimaging and electrophysiological research Blood brain barrier transport Toxicology and safety Homeland security/national defense Immuno-oncology Intracellular biologic therapies Medical countermeasures Formulation design Biomarker discovery, development, validation Collaborative models SRI Biosciences takes on the toughest biomedical challenges with transformative approaches and platforms. We partner closely with clients in areas including: Co-development/licensing Federal subcontract teaming Grant teaming Incubator space and services Joint business partnerships Regulatory support Technology platforms There are many talented researchers from various disciplines at SRI. This creates an exciting environment and fertile ground for cutting edge research thanks to the cooperation of different teams. This highly effective collaboration allows SRI to invent and develop unique and novel products and technologies. Michal Avital-Shmilovici Research Scientist, Biosciences Division Featured publications Performance of Fitbit Charge 3 Against Polysomnography in Measuring Sleep in Adolescent Boys and Girls SRI Authors: Dilara Yüksel, Fiona C Baker, Massimiliano de Zambotti ARTICLE APRIL 1, 2021 Share Physiological Responses to Acute Psychosocial Stress in Women with Menopausal Insomnia SRI Authors: Dilara Yüksel, Massimiliano de Zambotti, Tilman Schulte, Ian M. Colrain, Fiona C Baker JOURNAL ARTICLE FEBRUARY 26, 2021 Share Sleep and Circadian Regulation of the Autonomic Nervous System SRI Authors: Massimiliano de Zambotti, Fiona C Baker ARTICLE FEBRUARY 24, 2021 Share Search publications How can we help? Once you hit send… We’ll match your inquiry to the person who can best help you. Expect a response within 48 hours. OUR PRIVACY POLICY Make your own mark. SEARCH JOBS OUR WORK Case studies Publications Timeline of innovation Areas of expertise Blog INSTITUTE Leadership Press room and media inquiries Compliance Privacy Policy CAREERS Job listings CONTACT SRI Ventures Our locations Headquarters 333 Ravenswood Ave Menlo Park, CA 94025 USA +1 (650) 859-2000 SUBSCRIBE TO OUR NEWSLETTER 日本支社 PRIVACY POLICY COOKIES DMCA ©2021 SRI INTERNATIONAL